APO Research
Talk to an analyst

APO RESEARCH · REPORT

Major Histocompatibility Complex

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Major Histocompatibility Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026185 pages

Choose your research edition.

Industry ResearchMajor Histocompatibility Complex Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Major Histocompatibility Complex Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Major Histocompatibility Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Major Histocompatibility Complex Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Major Histocompatibility Complex Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Major Histocompatibility Complex market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Major Histocompatibility Complex include Santa Cruz Biotechnology, ProImmune, Novus Biologicals, Miltenyi Biotec, Creative BioMart and Abbexa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Major Histocompatibility Complex market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Major Histocompatibility Complex and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Major Histocompatibility Complex revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Major Histocompatibility Complex market size, projected growth trends, production technologies, key applications, and end-use industries.

Major Histocompatibility Complex Segment by Company

Santa Cruz Biotechnology

ProImmune

Novus Biologicals

Miltenyi Biotec

Creative BioMart

Abbexa

Major Histocompatibility Complex Segment by Type

MHC Class II

MHC Class III

MHC Class I

Major Histocompatibility Complex Segment by Application

Medical Care

Research

Other

Major Histocompatibility Complex Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Histocompatibility Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Major Histocompatibility Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Histocompatibility Complex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Major Histocompatibility Complex in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Major Histocompatibility Complex industry.

Chapter 3: Detailed analysis of Major Histocompatibility Complex companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Major Histocompatibility Complexrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Major Histocompatibility Complex Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of MHC Class II Table 3. Key Players of MHC Class III Table 4. Key Players of MHC Class I Table 4. Global Major Histocompatibility Complex Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Care Table 6. Key Players of Research Table 7. Key Players of Other Table 8. Global Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Major Histocompatibility Complex Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Major Histocompatibility Complex Market Share by Region (2021-2026) Table 11. Global Major Histocompatibility Complex Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Major Histocompatibility Complex Market Share by Region (2027-2032) Table 13. Major Histocompatibility Complex Industry Trends Table 14. Major Histocompatibility Complex Industry Drivers Table 15. Major Histocompatibility Complex Industry Opportunities and Challenges Table 16. Major Histocompatibility Complex Industry Restraints Table 17. Global Major Histocompatibility Complex Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Major Histocompatibility Complex Revenue Market Share by Company (2021-2026) Table 19. Global Major Histocompatibility Complex Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Major Histocompatibility Complex Key Company Head Office and Area Served Table 21. Global Major Histocompatibility Complex Company, Product Type & Application Table 22. Global Major Histocompatibility Complex Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Major Histocompatibility Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Major Histocompatibility Complex Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Major Histocompatibility Complex Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Major Histocompatibility Complex Revenue Market Share by Type (2021-2026) Table 29. Global Major Histocompatibility Complex Revenue Market Share by Type (2027-2032) Table 30. Global Major Histocompatibility Complex Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Major Histocompatibility Complex Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Major Histocompatibility Complex Revenue Market Share by Application (2021-2026) Table 34. Global Major Histocompatibility Complex Revenue Market Share by Application (2027-2032) Table 35. Santa Cruz Biotechnology Company Information Table 36. Santa Cruz Biotechnology Business Overview Table 37. Santa Cruz Biotechnology Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio Table 39. Santa Cruz Biotechnology Recent Development Table 40. ProImmune Company Information Table 41. ProImmune Business Overview Table 42. ProImmune Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. ProImmune Major Histocompatibility Complex Product Portfolio Table 44. ProImmune Recent Development Table 45. Novus Biologicals Company Information Table 46. Novus Biologicals Business Overview Table 47. Novus Biologicals Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novus Biologicals Major Histocompatibility Complex Product Portfolio Table 49. Novus Biologicals Recent Development Table 50. Miltenyi Biotec Company Information Table 51. Miltenyi Biotec Business Overview Table 52. Miltenyi Biotec Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Miltenyi Biotec Major Histocompatibility Complex Product Portfolio Table 54. Miltenyi Biotec Recent Development Table 55. Creative BioMart Company Information Table 56. Creative BioMart Business Overview Table 57. Creative BioMart Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Creative BioMart Major Histocompatibility Complex Product Portfolio Table 59. Creative BioMart Recent Development Table 60. Abbexa Company Information Table 61. Abbexa Business Overview Table 62. Abbexa Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Abbexa Major Histocompatibility Complex Product Portfolio Table 64. Abbexa Recent Development Table 65. North America Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Major Histocompatibility Complex Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Major Histocompatibility Complex Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Major Histocompatibility Complex Market Size by Country (2021-2026) Table 71. North America Major Histocompatibility Complex Market Size by Country (2027-2032) Table 72. Europe Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Major Histocompatibility Complex Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Major Histocompatibility Complex Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Major Histocompatibility Complex Market Size by Country (2021-2026) Table 78. Europe Major Histocompatibility Complex Market Size by Country (2027-2032) Table 79. China Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 80. China Major Histocompatibility Complex Market Size by Type (2027-2032) & (US$ Million) Table 81. China Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 82. China Major Histocompatibility Complex Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Major Histocompatibility Complex Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Major Histocompatibility Complex Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Major Histocompatibility Complex Market Size by Country (2021-2026) Table 89. Asia Major Histocompatibility Complex Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Major Histocompatibility Complex Product Image Figure 2. Global Major Histocompatibility Complex Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Major Histocompatibility Complex Market Share by Type: 2025 VS 2032 Figure 4. MHC Class II Image Figure 5. MHC Class III Image Figure 6. MHC Class I Image Figure 7. Global Major Histocompatibility Complex Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Major Histocompatibility Complex Market Share by Application: 2025 VS 2032 Figure 9. Medical Care Image Figure 10. Research Image Figure 11. Other Image Figure 12. Global Major Histocompatibility Complex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 14. Global Major Histocompatibility Complex Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Major Histocompatibility Complex Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Major Histocompatibility Complex Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Major Histocompatibility Complex Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Major Histocompatibility Complex Revenue Market Share by Type (2021-2032) Figure 21. Global Major Histocompatibility Complex Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Major Histocompatibility Complex Revenue Market Share by Application (2021-2032) Figure 23. North America Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 24. North America Major Histocompatibility Complex Market Share by Type (2021-2032) Figure 25. North America Major Histocompatibility Complex Market Share by Application (2021-2032) Figure 26. North America Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 27. United States Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 28. Canada Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 30. Europe Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 31. Europe Major Histocompatibility Complex Market Share by Type (2021-2032) Figure 32. Europe Major Histocompatibility Complex Market Share by Application (2021-2032) Figure 33. Europe Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 34. Germany Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 35. France Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 37. Italy Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 38. Russia Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 40. China Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 41. China Major Histocompatibility Complex Market Share by Type (2021-2032) Figure 42. China Major Histocompatibility Complex Market Share by Application (2021-2032) Figure 43. Asia Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 44. Asia Major Histocompatibility Complex Market Share by Type (2021-2032) Figure 45. Asia Major Histocompatibility Complex Market Share by Application (2021-2032) Figure 46. Asia Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 47. Japan Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 51. India Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 52. Australia Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Major Histocompatibility Complex Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Major Histocompatibility Complex Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 57. Brazil Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 62. UAE Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 64. Chile Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • MHC Class II
  • MHC Class III
  • MHC Class I
Applications
  • Medical Care
  • Research
  • Other
Companies covered
  • Santa Cruz Biotechnology
  • ProImmune
  • Novus Biologicals
  • Miltenyi Biotec
  • Creative BioMart
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Major Histocompatibility Complex Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 MHC Class II
  5. 1.2.3 MHC Class III
  6. 1.2.4 MHC Class I
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Major Histocompatibility Complex Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Care
  10. 1.3.3 Research
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Major Histocompatibility Complex Growth Trends by Region
  14. 1.5.1 Global Major Histocompatibility Complex Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Major Histocompatibility Complex Market Size by Region (2021-2026)
  16. 1.5.3 Major Histocompatibility Complex Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Major Histocompatibility Complex Market Dynamics
  1. 2.1 Major Histocompatibility Complex Industry Trends
  2. 2.2 Major Histocompatibility Complex Industry Drivers
  3. 2.3 Major Histocompatibility Complex Industry Opportunities and Challenges
  4. 2.4 Major Histocompatibility Complex Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Major Histocompatibility Complex Revenue by Company (2021-2026)
  2. 3.2 Global Major Histocompatibility Complex Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Major Histocompatibility Complex Key Company Head office and Area Served
  4. 3.4 Global Major Histocompatibility Complex Company, Product Type & Application
  5. 3.5 Global Major Histocompatibility Complex Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Major Histocompatibility Complex Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Major Histocompatibility Complex Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Major Histocompatibility Complex Tier 1, Tier 2, and Tier 3
4 Major Histocompatibility Complex Market by Type
  1. 4.1 Global Major Histocompatibility Complex Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Major Histocompatibility Complex Market Size by Type (2021-2032)
  3. 4.3 Global Major Histocompatibility Complex Market Size Share by Type (2021-2032)
5 Major Histocompatibility Complex Market by Application
  1. 5.1 Global Major Histocompatibility Complex Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Major Histocompatibility Complex Market Size by Application (2021-2032)
  3. 5.3 Global Major Histocompatibility Complex Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Santa Cruz Biotechnology
  2. 6.1.1 Santa Cruz Biotechnology Company Information
  3. 6.1.2 Santa Cruz Biotechnology Business Overview
  4. 6.1.3 Santa Cruz Biotechnology Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio
  6. 6.1.5 Santa Cruz Biotechnology Recent Developments
  7. 6.2 ProImmune
  8. 6.2.1 ProImmune Company Information
  9. 6.2.2 ProImmune Business Overview
  10. 6.2.3 ProImmune Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 ProImmune Major Histocompatibility Complex Product Portfolio
  12. 6.2.5 ProImmune Recent Developments
  13. 6.3 Novus Biologicals
  14. 6.3.1 Novus Biologicals Company Information
  15. 6.3.2 Novus Biologicals Business Overview
  16. 6.3.3 Novus Biologicals Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novus Biologicals Major Histocompatibility Complex Product Portfolio
  18. 6.3.5 Novus Biologicals Recent Developments
  19. 6.4 Miltenyi Biotec
  20. 6.4.1 Miltenyi Biotec Company Information
  21. 6.4.2 Miltenyi Biotec Business Overview
  22. 6.4.3 Miltenyi Biotec Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Miltenyi Biotec Major Histocompatibility Complex Product Portfolio
  24. 6.4.5 Miltenyi Biotec Recent Developments
  25. 6.5 Creative BioMart
  26. 6.5.1 Creative BioMart Company Information
  27. 6.5.2 Creative BioMart Business Overview
  28. 6.5.3 Creative BioMart Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Creative BioMart Major Histocompatibility Complex Product Portfolio
  30. 6.5.5 Creative BioMart Recent Developments
  31. 6.6 Abbexa
  32. 6.6.1 Abbexa Company Information
  33. 6.6.2 Abbexa Business Overview
  34. 6.6.3 Abbexa Major Histocompatibility Complex Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Abbexa Major Histocompatibility Complex Product Portfolio
  36. 6.6.5 Abbexa Recent Developments
7 North America
  1. 7.1 North America Major Histocompatibility Complex Market Size (2021-2032)
  2. 7.2 North America Major Histocompatibility Complex Market Size by Type
  3. 7.2.1 North America Major Histocompatibility Complex Market Size by Type (2021-2026)
  4. 7.2.2 North America Major Histocompatibility Complex Market Size by Type (2027-2032)
  5. 7.2.3 North America Major Histocompatibility Complex Market Share by Type (2021-2032)
  6. 7.3 North America Major Histocompatibility Complex Market Size by Application
  7. 7.3.1 North America Major Histocompatibility Complex Market Size by Application (2021-2026)
  8. 7.3.2 North America Major Histocompatibility Complex Market Size by Application (2027-2032)
  9. 7.3.3 North America Major Histocompatibility Complex Market Share by Application (2021-2032)
  10. 7.4 North America Major Histocompatibility Complex Market Size by Country
  11. 7.4.1 North America Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Major Histocompatibility Complex Market Size by Country (2021-2026)
  13. 7.4.3 North America Major Histocompatibility Complex Market Size by Country (2027-2032)
  14. 7.4.4 North America Major Histocompatibility Complex Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Major Histocompatibility Complex Market Size (2021-2032)
  2. 8.2 Europe Major Histocompatibility Complex Market Size by Type
  3. 8.2.1 Europe Major Histocompatibility Complex Market Size by Type (2021-2026)
  4. 8.2.2 Europe Major Histocompatibility Complex Market Size by Type (2027-2032)
  5. 8.2.3 Europe Major Histocompatibility Complex Market Share by Type (2021-2032)
  6. 8.3 Europe Major Histocompatibility Complex Market Size by Application
  7. 8.3.1 Europe Major Histocompatibility Complex Market Size by Application (2021-2026)
  8. 8.3.2 Europe Major Histocompatibility Complex Market Size by Application (2027-2032)
  9. 8.3.3 Europe Major Histocompatibility Complex Market Share by Application (2021-2032)
  10. 8.4 Europe Major Histocompatibility Complex Market Size by Country
  11. 8.4.1 Europe Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Major Histocompatibility Complex Market Size by Country (2021-2026)
  13. 8.4.3 Europe Major Histocompatibility Complex Market Size by Country (2027-2032)
  14. 8.4.4 Europe Major Histocompatibility Complex Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Major Histocompatibility Complex Market Size (2021-2032)
  2. 9.2 China Major Histocompatibility Complex Market Size by Type
  3. 9.2.1 China Major Histocompatibility Complex Market Size by Type (2021-2026)
  4. 9.2.2 China Major Histocompatibility Complex Market Size by Type (2027-2032)
  5. 9.2.3 China Major Histocompatibility Complex Market Share by Type (2021-2032)
  6. 9.3 China Major Histocompatibility Complex Market Size by Application
  7. 9.3.1 China Major Histocompatibility Complex Market Size by Application (2021-2026)
  8. 9.3.2 China Major Histocompatibility Complex Market Size by Application (2027-2032)
  9. 9.3.3 China Major Histocompatibility Complex Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Major Histocompatibility Complex Market Size (2021-2032)
  2. 10.2 Asia Major Histocompatibility Complex Market Size by Type
  3. 10.2.1 Asia Major Histocompatibility Complex Market Size by Type (2021-2026)
  4. 10.2.2 Asia Major Histocompatibility Complex Market Size by Type (2027-2032)
  5. 10.2.3 Asia Major Histocompatibility Complex Market Share by Type (2021-2032)
  6. 10.3 Asia Major Histocompatibility Complex Market Size by Application
  7. 10.3.1 Asia Major Histocompatibility Complex Market Size by Application (2021-2026)
  8. 10.3.2 Asia Major Histocompatibility Complex Market Size by Application (2027-2032)
  9. 10.3.3 Asia Major Histocompatibility Complex Market Share by Application (2021-2032)
  10. 10.4 Asia Major Histocompatibility Complex Market Size by Country
  11. 10.4.1 Asia Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Major Histocompatibility Complex Market Size by Country (2021-2026)
  13. 10.4.3 Asia Major Histocompatibility Complex Market Size by Country (2027-2032)
  14. 10.4.4 Asia Major Histocompatibility Complex Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Major Histocompatibility Complex Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Major Histocompatibility Complex Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Major Histocompatibility Complex Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Major Histocompatibility Complex Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Major Histocompatibility Complex Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst